Literature DB >> 17601658

Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review.

Laura M Lynam1, Mark K Lyons, Joseph F Drazkowski, Joseph I Sirven, Katherine H Noe, Richard S Zimmerman, James A Wilkens.   

Abstract

Brain tumors may lead to symptomatic epilepsy. A retrospective analysis was undertaken to evaluate the frequency of seizure as the presenting symptom leading to brain tumor diagnosis in adults. One hundred and forty-seven consecutive patients with newly diagnosed brain tumors were analyzed regarding the frequency of seizures as the initial presenting symptoms and those subsequently developing seizures. One hundred twelve patients had primary central nervous system tumors (CNS) and 35 had metastatic lesions. Statistical evaluation was carried out using the Chi-square test with p values of <0.05 considered to be statistically significant. Astrocytomas and meningiomas were the most common primary CNS tumors in this study. Of these, oligodendrogliomas and grade 2 astrocytomas were significantly more likely to present with seizures (p<0.001). Seizures were a frequent presenting symptom, occurring in over 38% of those with primary brain neoplasms and 20% of those with cerebral metastases. Primary location of tumor also correlated amongst primary CNS tumors and was associated with a trend in seizure risk: parietal (80%); temporal (74%); frontal (62%); and occipital (0%) (p<0.5). The findings highlight the importance of obtaining appropriate evaluation for underlying malignancy in adults with new-onset seizures as well as provide more information to the patient for prognosis and counseling.

Entities:  

Mesh:

Year:  2007        PMID: 17601658     DOI: 10.1016/j.clineuro.2007.05.017

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  45 in total

Review 1.  Translational potential of astrocytes in brain disorders.

Authors:  Alexei Verkhratsky; Luca Steardo; Vladimir Parpura; Vedrana Montana
Journal:  Prog Neurobiol       Date:  2015-09-16       Impact factor: 11.685

Review 2.  Epilepsy: A Spectrum Disorder.

Authors:  Joseph I Sirven
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-01       Impact factor: 6.915

Review 3.  Treatment of epileptic seizures in brain tumors: a critical review.

Authors:  R Bauer; M Ortler; M Seiz-Rosenhagen; R Maier; J V Anton; I Unterberger
Journal:  Neurosurg Rev       Date:  2014-04-24       Impact factor: 3.042

4.  Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma.

Authors:  Andrés F Cardona; Leonardo Rojas; Beatriz Wills; Laura Bernal; Alejandro Ruiz-Patiño; Oscar Arrieta; Enrique Jiménez Hakim; Fernando Hakim; Juan Armando Mejía; Nicolás Useche; Sonia Bermúdez; Hernán Carranza; Carlos Vargas; Jorge Otero; Luis Carlos Mayor; León Darío Ortíz; Sandra Franco; Carlos Ortíz; Miguel Gil-Gil; Carmen Balaña; Zyanya Lucia Zatarain-Barrón
Journal:  J Neurooncol       Date:  2017-11-25       Impact factor: 4.130

5.  Non-convulsive status epilepticus in brain tumors.

Authors:  M Casazza; I Gilioli
Journal:  Neurol Sci       Date:  2011-11       Impact factor: 3.307

Review 6.  Prophylactic anticonvulsants in patients with primary glioblastoma.

Authors:  Arvin R Wali; Robert C Rennert; Sonya G Wang; Clark C Chen
Journal:  J Neurooncol       Date:  2017-07-28       Impact factor: 4.130

Review 7.  Brain Tumor-Related Epilepsy: a Current Review of the Etiologic Basis and Diagnostic and Treatment Approaches.

Authors:  Jeffrey M Politsky
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09       Impact factor: 5.081

8.  Outcomes after discontinuation of antiepileptic drugs after surgery in patients with low grade brain tumors and meningiomas.

Authors:  Rohit R Das; Elinor Artsy; Shelley Hurwitz; Patrick Y Wen; Peter Black; Alexandra Golby; Barbara Dworetzky; Jong Woo Lee
Journal:  J Neurooncol       Date:  2012-01-03       Impact factor: 4.130

Review 9.  Glutamate and tumor-associated epilepsy: glial cell dysfunction in the peritumoral environment.

Authors:  Susan C Buckingham; Stefanie Robel
Journal:  Neurochem Int       Date:  2013-02-04       Impact factor: 3.921

Review 10.  Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments.

Authors:  Roberta Rudà; Lorenzo Bello; Hugues Duffau; Riccardo Soffietti
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.